• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过协同调控网络方法鉴定的8种 microRNA 在肺癌中的致癌和预后潜力

The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.

作者信息

Mitra Ramkrishna, Zhao Zhongming

机构信息

Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

Departments of Biomedical Informatics, Psychiatry, and Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

出版信息

Int J Comput Biol Drug Des. 2014;7(4):384-93. doi: 10.1504/IJCBDD.2014.066572. Epub 2014 Dec 25.

DOI:10.1504/IJCBDD.2014.066572
PMID:25539849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4779644/
Abstract

Transcription factors (TFs) and microRNAs (miRNAs), the two main gene regulators in the biological system, control the gene expression at the transcriptional and post-transcriptional level, respectively. However, little is known regarding whether the miRNATF co-regulatory mechanisms, predicted by several studies, truly reflect the molecular interactions in cellular systems. To tackle this important issue, we developed an integrative framework by utilising four independent miRNA and matched mRNA expression profiling datasets to identify reproducible regulations, and demonstrated this approach in non-small cell lung cancer (NSCLC). Our analyses pinpointed several reproducible miRNA-TF co-regulatory networks in NSCLC from which we systematically prioritised eight hub miRNAs that may have strong oncogenic characteristics. Here, we discussed the major findings of our study and explored the oncogenic and prognostic potential of eight prioritised miRNAs through literature-mining based analysis and patient survival analysis. The findings provide additional insights into the miRNA-TF co-regulation in lung cancer.

摘要

转录因子(TFs)和微小RNA(miRNAs)是生物系统中的两种主要基因调节因子,分别在转录水平和转录后水平控制基因表达。然而,关于几项研究预测的miRNA-TF共同调节机制是否真的反映了细胞系统中的分子相互作用,目前所知甚少。为了解决这个重要问题,我们开发了一个综合框架,利用四个独立的miRNA和匹配的mRNA表达谱数据集来识别可重复的调节,并在非小细胞肺癌(NSCLC)中展示了这种方法。我们的分析确定了NSCLC中几个可重复的miRNA-TF共同调节网络,从中我们系统地筛选出了八个可能具有强大致癌特征的关键miRNA。在此,我们讨论了研究的主要发现,并通过基于文献挖掘的分析和患者生存分析,探索了八个筛选出的miRNA的致癌和预后潜力。这些发现为肺癌中的miRNA-TF共同调节提供了更多见解。

相似文献

1
The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.通过协同调控网络方法鉴定的8种 microRNA 在肺癌中的致癌和预后潜力
Int J Comput Biol Drug Des. 2014;7(4):384-93. doi: 10.1504/IJCBDD.2014.066572. Epub 2014 Dec 25.
2
Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.可重复的组合调控网络揭示了非小细胞肺癌中的新型致癌 microRNA。
RNA. 2014 Sep;20(9):1356-68. doi: 10.1261/rna.042754.113. Epub 2014 Jul 14.
3
A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.一种用于推断特定条件下转录因子和微小RNA对蛋白质-蛋白质相互作用的协同调控的新型框架。
Gene. 2016 Feb 10;577(1):55-64. doi: 10.1016/j.gene.2015.11.023. Epub 2015 Nov 27.
4
Clinical implication of microrna for lung cancer.微小RNA对肺癌的临床意义
Cancer Biother Radiopharm. 2013 May;28(4):261-7. doi: 10.1089/cbr.2012.1401. Epub 2013 Mar 15.
5
A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.系统生物学方法分析非小细胞肺癌中 miRNA-mRNA 表达模式。
Cancer Biomark. 2016;16(1):31-45. doi: 10.3233/CBM-150538.
6
Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.从全基因组血清 microRNA 表达谱中鉴定出的十个血清 microRNAs 作为非小细胞肺癌诊断的新型无创生物标志物。
Int J Cancer. 2012 Apr 1;130(7):1620-8. doi: 10.1002/ijc.26177. Epub 2011 Aug 3.
7
Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer.基于非小细胞肺癌中调控基序识别的微小RNA与转录因子协同调控网络的功能分析
BMC Syst Biol. 2013 Nov 7;7:122. doi: 10.1186/1752-0509-7-122.
8
miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.miR-1254 和 miR-574-5p:基于血清的早期非小细胞肺癌 microRNA 生物标志物。
J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785.
9
microRNA and Lung Cancer.微小RNA与肺癌
Adv Exp Med Biol. 2015;889:153-77. doi: 10.1007/978-3-319-23730-5_9.
10
Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.血浆中miR-204表达降低与非小细胞肺癌患者的不良预后相关。
Int J Mol Med. 2015 Dec;36(6):1720-6. doi: 10.3892/ijmm.2015.2388. Epub 2015 Oct 22.

引用本文的文献

1
Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.基于系统药理学通过靶向癌症突变基因发现用于精准肿瘤学的天然产物
CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):177-187. doi: 10.1002/psp4.12172. Epub 2017 Mar 14.
2
Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers.调控重布线分析揭示了STAT1与miR-155-5p在七种主要癌症的肿瘤免疫监视中的相互调控。
Sci Rep. 2015 Jul 9;5:12063. doi: 10.1038/srep12063.

本文引用的文献

1
Gene regulatory networks by transcription factors and microRNAs in breast cancer.乳腺癌中由转录因子和微小RNA构成的基因调控网络
Bioinformatics. 2015 Jan 1;31(1):76-83. doi: 10.1093/bioinformatics/btu597. Epub 2014 Sep 3.
2
Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.可重复的组合调控网络揭示了非小细胞肺癌中的新型致癌 microRNA。
RNA. 2014 Sep;20(9):1356-68. doi: 10.1261/rna.042754.113. Epub 2014 Jul 14.
3
miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.miR-141和miR-200c作为早期非小细胞肺癌腺癌总生存期的标志物。
PLoS One. 2014 Jul 8;9(7):e101899. doi: 10.1371/journal.pone.0101899. eCollection 2014.
4
miRBase: annotating high confidence microRNAs using deep sequencing data.miRBase:利用深度测序数据注释高可信度 microRNAs。
Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73. doi: 10.1093/nar/gkt1181. Epub 2013 Nov 25.
5
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.miRNA-31 与 BRAF 突变、结直肠癌生存和锯齿状途径的关联
Carcinogenesis. 2014 Apr;35(4):776-83. doi: 10.1093/carcin/bgt374. Epub 2013 Nov 15.
6
Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer.浆液性卵巢癌中由致癌基因驱动的微小RNA和转录因子介导的协同调控网络。
Mol Biosyst. 2013 Dec;9(12):3187-98. doi: 10.1039/c3mb70172g. Epub 2013 Oct 16.
7
Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.miR-9 表达上调可作为非小细胞肺癌患者预后不良的生物标志物。
Clin Transl Oncol. 2014 May;16(5):469-75. doi: 10.1007/s12094-013-1106-1. Epub 2013 Sep 10.
8
How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.微小 RNA 和转录因子共同调控网络如何影响骨肉瘤细胞增殖。
PLoS Comput Biol. 2013;9(8):e1003210. doi: 10.1371/journal.pcbi.1003210. Epub 2013 Aug 29.
9
Topological patterns in microRNA-gene regulatory network: studies in colorectal and breast cancer.微小RNA-基因调控网络中的拓扑模式:结直肠癌和乳腺癌研究
Mol Biosyst. 2013 Jun;9(6):1360-71. doi: 10.1039/c3mb25518b. Epub 2013 Mar 11.
10
Prognostic significance of serum miR-17-5p in lung cancer.血清 miR-17-5p 在肺癌中的预后意义。
Med Oncol. 2013 Mar;30(1):353. doi: 10.1007/s12032-012-0353-2. Epub 2012 Dec 24.